Cancer has overtaken cardiovascular disease, which includes heart disease and stroke, as the UK's No 1 killer—but only among men, reveals research published online in the journal Heart.
The researchers used the latest nationally available data (2012-13) for each of the four UK countries and the Cardiovascular Disease Statistics 2014 report compiled for the British Heart Foundation (BHF) to quantify the prevalence of cardiovascular disease, and find out how it's treated, how much it costs, and how many deaths it causes.Cardiovascular disease is still the most common cause of death among women, and kills more young women than breast cancer, the figures show.
Cardiovascular disease includes coronary heart disease, stroke, high blood pressure, circulatory system disease, and other vascular/arterial disease.
The researchers analysed entries to the Clinical Practice Research Datalink GOLD database, the world's largest repository of anonymised records for primary care, plus information from the family doctor (GP) quality improvement scheme known as QOF, and figures on episodes of inpatient hospital care.
The analysis indicated that just short of 2.3 million people were living with some form of coronary heart disease in 2012. Around half a million were living with heart failure and a further 1.1 million were living with abnormal heart rhythm (atrial fibrillation).
England had the lowest prevalence of all cardiovascular conditions out of the four UK countries. But there were regional variations, with higher rates of cardiovascular disease in the North of England than in the South of the country.
Scotland had the highest prevalence of coronary heart disease, stroke, and peripheral vascular disease, while Wales had the highest prevalence of high blood pressure, heart failure, and atrial fibrillation.
Once again, there were wide regional variations in death rates. There were higher rates in Scotland (347/100,000 of the population) and the North of England (320/100,000), and lower rates in the South of England.
The City of Glasgow topped the league table for death rates from cardiovascular disease for all ages, including premature deaths.
The number of surgical procedures and drugs prescribed to treat and prevent cardiovascular disease has risen substantially over the past two decades, and in 2012-13 the NHS spent just under £7 billion in England alone on cardiovascular disease, the largest chunk of which was spent on hospital care.
The equivalent cost in Wales was £442.3 million, £393 million in Northern Ireland, and more than £750 million in Scotland.
"Cardiovascular disease remains a substantial burden to the UK, both in terms of health and economic costs," write the researchers, highlighting the "stark regional inequalities in the mortality and prevalence of [cardiovascular disease]."
In a linked editorial, Dr Adam Timmis, of the NIHR Cardiovascular Biomedical Research Unit at Barts Health, London, describes the more than 40% drop in cardiovascular disease death rates since 1960 as "among the greatest public health triumphs in the past 50 years." But the continuing North-South divide is a "stain on the UK's public health record," he writes.
The [BHF] report provides a timely reminder that in young women too [cardiovascular disease] kills more women than breast cancer. Most of these deaths in young women are caused by myocardial infarction [heart attack] which is largely preventable through modification of risk factors," he points out.
"And if the national effort put into the detection of breast cancer could be matched in protecting young women against myocardial infarction many more lives would probably be saved," he insists.
Explore further: Rates of heart disease and stroke continue to decline in Europe
More information: The epidemiology of cardiovascular disease in the UK 2014, Heart, DOI: 10.1136/heartjnl-2015-307516
Editorial: Cardiovascular mortality in the UK: good news if you live in the South, Heart, DOI: 10.1136/heartjnl-2015-307887
Editorial: Cardiovascular mortality in the UK: good news if you live in the South, Heart, DOI: 10.1136/heartjnl-2015-307887
No comments:
Post a Comment